Alnylam Pharmaceuticals is responsible for the funding and content of this website. The site is intended for the general public in Canada for disease awareness purposes only. Nothing on the site constitutes individual medical advice. Individuals are advised to consult their physician or other appropriate HCP. PH1-CAN-00001 | May 2022